The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials

Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

(2016) Sara Heebøll et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial

(2015) Sony S Thazhath et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study

(2015) Forouzan Faghihzadeh et al.   BRITISH JOURNAL OF NUTRITION

Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials

(2015) Yanxia Liu et al.   CLINICAL NUTRITION

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

(2015) Shihui Chen et al.   DIGESTIVE AND LIVER DISEASE

Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial

(2015) Sanne M. van der Made et al.   PLoS One

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

(2014) Kai Liu et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

(2014) Veronique S. Chachay et al.   Clinical Gastroenterology and Hepatology

The Clinical Practice Recommendations of the German Diabetes Association

(2014)   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study

(2014) Stephen D. Anton et al.   EXPERIMENTAL GERONTOLOGY

Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults

(2014) A. V. Witte et al.   JOURNAL OF NEUROSCIENCE

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

(2014) Miriam Méndez-del Villar et al.   Metabolic Syndrome and Related Disorders

Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis

(2014) Heather A. Hausenblas et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Assessment of diet quality improves the classification ability of cardiovascular risk score in predicting future events: The 10-year follow-up of the ATTICA study (2002–2012)

(2014) Ekavi N Georgousopoulou et al.   European Journal of Preventive Cardiology

Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective

(2013) João Tomé-Carneiro et al.   Annals of the New York Academy of Sciences

High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men

(2013) Satya Dash et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

(2013) Ali Movahed et al.   Evidence-based Complementary and Alternative Medicine

Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults

(2013) Rachel H.X. Wong et al.   JOURNAL OF HYPERTENSION

Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men

(2013) Lasse Gliemann et al.   JOURNAL OF PHYSIOLOGY-LONDON

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

(2012) João Tomé-Carneiro et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inflammation and metabolic dysfunction: links to cardiovascular diseases

(2012) Annika Taube et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease

(2012) João Tomé-Carneiro et al.   CARDIOVASCULAR DRUGS AND THERAPY

High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

(2012) M. M. Poulsen et al.   DIABETES

Obesity, inflammation and the immune system

(2012) Fátima Pérez de Heredia et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease

(2011) C Herder et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Residual cardiovascular risk in secondary prevention

(2011) Alberto Zambon   Internal and Emergency Medicine

Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment

(2011) Keisuke Fujitaka et al.   NUTRITION RESEARCH

Resveratrol and cardiovascular health

(2010) Manika Das et al.   MOLECULAR ASPECTS OF MEDICINE

Central Administration of Resveratrol Improves Diet-Induced Diabetes

(2009) Giorgio Ramadori et al.   ENDOCRINOLOGY

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE